|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 49/00 | |
| C07K 14/00 | |||
| C40B 50/00 | |||
| C40B 40/08 | |||
| C40B 40/02 | |||
| C40B 30/04 | |||
| C07H 21/00 | |||
| C12N 15/63 | |||
| C12N 1/21 | |||
| C12N 1/19 | |||
| C12N 5/10 | |||
| A61K 38/16 | |||
| A61P 25/00 | |||
| A61K 38/22 | |||
| A61P 7/00 | |||
| A61P 27/02 | |||
| A61P 35/00 | |||
| A61P 9/00 |
| (11) | Patento numeris | 3103478 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16175500.4 |
| Europos patento paraiškos padavimo data | 2011-04-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-12-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-04-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 329980 P | 2010-04-30 | US |
| (72) |
JACOBS, Steven, US
|
| (73) |
Janssen Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (54) | STABILIZED FIBRONECTIN DOMAIN COMPOSITIONS, METHODS AND USES |
| STABILIZED FIBRONECTIN DOMAIN COMPOSITIONS, METHODS AND USES |